In multivariate analysis, only low FSTL1 expression (hazard ratio [HR] = 2.55; 95% confidence interval [CI] = 1.04–6.24; P = 0.041) and lymph node metastasis (HR = 2.62; 95% CI = 1.26–5.46; P = 0.010) remained independently prognostic. This evidence concerns the gene FSTL1 and metastatic malignant neoplasm in the lymph nodes.